Monaco Asset Management SAM

Position in NVAX — Novavax Inc

CIK 1803593 Monaco, O9

Position in NVAX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$5,439,710

-$238,754 QoQ

Shares Held

577,464

-17.2% QoQ

Ownership

0.350%

of shares outstanding

% of Portfolio

2.09%

of 13F equity value

Holder Rank

#28

of 263 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Monaco Asset Management SAM holds $49,930,003 across 9 Biotechnology names. NVAX ranks #5 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRVI	Maravai Lifesciences Holdings, Inc.	2,231,026	$13,921,602
2	BMRN	Biomarin Pharmaceutical Inc	184,937	$10,582,095
3	RCKT	Rocket Pharmaceuticals, Inc.	2,480,468	$8,483,200
4	NKTX	Nkarta, Inc.	2,373,400	$6,716,722
5	NVAX	Novavax Inc This page	577,464	$5,439,710
6	PLRX	Pliant Therapeutics, Inc.	1,938,747	$2,210,171
7	VNDA	Vanda Pharmaceuticals Inc.	221,286	$1,354,270
8	LKFT	Lakefront Biotherapeutics NV	25,600	$767,488

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,439,710	577,464	-17.2%	Shares	Sole	2026-08-07
2026-03-31	$5,678,464	697,600	-33.2%	Shares	Sole	2026-05-11
2025-12-31	$7,022,400	1,045,000	+161.2%	Shares	Sole	2026-02-10
2025-09-30	$3,468,000	400,000	+73.9%	Shares	Sole	2025-11-10
2025-06-30	$1,449,000	230,000	-20.7%	Shares	Sole	2025-08-07
2025-03-31	$1,858,900	290,000	+1.8%	Shares	Sole	2025-05-08
2024-12-31	$2,291,400	285,000	+356.0%	Shares	Sole	2025-02-10
2024-09-30	$789,375	62,500	-26.5%	Shares	Sole	2024-11-07
2024-06-30	$1,076,100	85,000	-55.0%	Shares	Sole	2024-08-07
2024-03-31	$902,942	188,900	+181.3%	Shares	Sole	2024-05-09
2023-12-31	$322,315	67,149	+123.8%	Shares	Sole	2024-02-07
2023-09-30	$217,200	30,000	-53.4%	Shares	Sole	2023-11-07
2023-06-30	$478,276	64,371	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.